American biotechnology company at Baltimore in Maryland, founded in 2016, which develops medicines from cannabis derived and other plant molecules. Works on cannflavin compounds and cannabinoid based candidates for cancer and inflammatory pain, holds patents on its lead molecules, has worked with the University of Maryland and other research partners, and takes programmes through preclinical study towards clinical trials.
No hay comentarios disponibles.
Deja tu valoración & comentario